{
    "nct_id": "NCT03429244",
    "official_title": "PSMA-PET for Biopsy and Treatment Guidance in Primary Prostate Cancer",
    "inclusion_criteria": "1. ≥ 18 years of age\n2. Must provide written informed consent\n3. Presence of low or intermediate risk prostate cancer or at risk of having intermediate risk cancer\n\n   a. Intermediate risk prostate cancer: i. Grade group 2 = 3 + 4, or ii. Grade group 3 = 4 + 3 b. At Risk of intermediate risk prostate cancer: i. 4K score ≥ 20%, or ii. Select MDx ≥ 20%, or iii. PSA Density ≥ 0.15 iv. Grade group 1= 3+3 (iv. Note: Where multiple cancer lesions are present on biopsy, it is allowable to have Gleason 8 or 9 cancer lesions if they are in addition to the intermediate risk cancer as described above.)\n4. Scheduled for MRI or has recently completed SOC MRI (within 6 months) for further biopsy, or surgical removal, or focal therapy.\n5. Willing and able to lie still for approximately 50 minutes in an enclosed space for the CT.\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Participation in another investigational trial involving research exposure to ionizing radiation concurrently or within 30 days.\n2. Does not meet safety criteria for MRI scan (e.g. metal implant that is not allowed).\n3. Significant acute or chronic medical, neurologic, or psychiatric illness in the subject that, in the judgment of the Principal Investigator, could compromise subject safety, limit the subject's ability to complete the study, and/or compromise the objectives of the study.",
    "miscellaneous_criteria": ""
}